Chromemax Pharmaceuticals Private Limited

Founded in 2017 and headquartered in Maharashtra, India.

2017 | Mumbai, Maharashtra (India) | Inactive
Last Updated: January 31, 2024

Chromemax Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Company Age 7 Year, 8 Months
  • Last Filing with ROC 31 Mar 2018

About Chromemax Pharmaceuticals

Chromemax Pharmaceuticals Private Limited (CPPL) is Strike Off company established on 15 May 2017 with its office registered at Mumbai, Maharashtra, India and has been running since 7 Year, 8 Months with a paid up capital of 0.00. According to MCA records, 2 Directors are linked to this company as of 31 Jan 2024.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U36900MH2017PTC294832

  • Company No.

    294832

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    15 May 2017

  • Date of AGM

    28 Sep 2018

  • Date of Balance Sheet

    31 Mar 2018

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Manufacturing

Who are the key members and board of directors at Chromemax Pharmaceuticals?

Board Members (2)

Name Designation Appointment Date Status
Chetan Jain Country flag representing In Director 15-May-2017 Current
Kalpesh Jain Country flag representing In Director 15-May-2017 Current

Financial Performance of Chromemax Pharmaceuticals.

Enhance accessibility to Chromemax Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of Chromemax Pharmaceuticals?

Unlock access to Chromemax Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Chromemax Pharmaceuticals?

Unlock and access historical data on people associated with Chromemax Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Chromemax Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chromemax Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Chromemax Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Chromemax Pharmaceuticals Private Limited last Annual general meeting of members was held on 28 Sep 2018 as per latest MCA records.

    28 Sep 2018

  • Balance Sheet

    Chromemax Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Mumbai.

    31 Mar 2018

  • Director Appointment

    Chetan Sampatraj Jain was appointed as a Director was appointed as a Director on 15 May 2017 & has been associated with this company since 7 years 8 months .

    15 May 2017

  • Director Appointment

    Kalpesh Prakashchand Jain was appointed as a Director was appointed as a Director on 15 May 2017 & has been associated with this company since 7 years 8 months .

    15 May 2017

  • Company Incorporation

    Chromemax Pharmaceuticals Private Limited was registered on 15 May 2017 with Roc Mumbai & aged 7 years 8 months as per MCA records.

    15 May 2017

Frequently asked questions

  • Chromemax Pharmaceuticals Private Limited was incorporated on 15 May 2017.

  • The authorized share capital of Chromemax Pharmaceuticals Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.00.

  • Currently 2 directors are associated with Chromemax Pharmaceuticals Private Limited.

    • Chetan Sampatraj Jain
    • Kalpesh Prakashchand Jain
  • As per Ministry of Corporate Affairs (Mca), the registered address of Chromemax Pharmaceuticals Private Limited is Shop No. 2 Siddhi Sai Building Sitaram, Sheth Chavan Marg Kakasaheb Gadgil Marg, Prabhadevi Mumbai Mumbai City, Maharashtra, India, 400025.

  • The corporate identification number (CIN) of Chromemax Pharmaceuticals Private Limited is U36900MH2017PTC294832 and the company number is 294832 as per Ministry of Corporate Affairs (MCA).

  • The most recent Balance Sheet for Chromemax Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2018.